Earningsreport

Q4/2024 12/31/2024 EPS -0.490 ZacksConsensus -0.440 ActVsEst (0.050) - Miss

C4 Therapeutics, Inc.  (CCCC) 
NASDAQ:AMEX Investor Relations: ir.chinacache.com